NCT06058819View on ClinicalTrials.gov

Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS

RecruitingOBSERVATIONAL
Enrollment

358

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Neonatal Late Onset Sepsis
Interventions
DIAGNOSTIC_TEST

Newborns suspected of Infections

This study will include NICU newborns of at least 7 days of life with suggestive signs of neonatal sepsis. The results will be extrapolated to this same population.

Trial Locations (3)

38700

RECRUITING

Hôpital Couple-Enfant - CHU Grenoble Alpes, Grenoble

44300

RECRUITING

Neonatal intensive care unit, Hôpital femme-maternité, Nantes

69500

RECRUITING

neonatal Intensive care unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, France, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER